Renal Cancer - Results from #2640

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma. July 21, 2020

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis. July 21, 2020

Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue? July 20, 2020

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial. July 20, 2020

Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression. July 17, 2020

Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. July 17, 2020

Comprehensive analysis of copy number variance and sensitivity to common targeted therapy in clear cell renal cell carcinoma: In silico analysis with in vitro validation. July 17, 2020

Transition from open partial nephrectomy directly to robotic surgery: experience of a single surgeon to achieve "TRIFECTA". July 16, 2020

Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma. July 16, 2020

Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China. July 16, 2020

The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial. July 15, 2020

Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study. July 15, 2020

Detection Of Tetraploidization In Chromophobe Renal Cell Carcinoma: Insights And Pitfalls. July 15, 2020

Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma. July 15, 2020

ImmunoPET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition. July 15, 2020

Serum long non-coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma. July 14, 2020

Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study. July 14, 2020

Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial. July 14, 2020

Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies. July 14, 2020

Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis. July 13, 2020

Page 133 of 456